Chemoinformaics analysis of (3R)-3alpha-Hydroxy-4beta-isopropylcyclohexene-1-carbaldehyde
| Molecular Weight | 288.431 | nRot | 7 |
| Heavy Atom Molecular Weight | 260.207 | nRig | 46 |
| Exact Molecular Weight | 288.209 | nRing | 1 |
| Solubility: LogS | -6.844 | nHRing | 0 |
| Solubility: LogP | 6.227 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 52.0042 |
| nHD | 0 | BPOL | 30.6938 |
| QED | 0.198 |
| Synth | 5.97 |
| Natural Product Likeliness | 1.827 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.987 |
| Pgp-sub | 0.093 |
| HIA | 0.01 |
| CACO-2 | -5.309 |
| MDCK | 0.0000279 |
| BBB | 0.027 |
| PPB | 0.887201 |
| VDSS | 0.515 |
| FU | 0.0703295 |
| CYP1A2-inh | 0.061 |
| CYP1A2-sub | 0.935 |
| CYP2c19-inh | 0.747 |
| CYP2c19-sub | 0.945 |
| CYP2c9-inh | 0.339 |
| CYP2c9-sub | 0.917 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.935 |
| CYP3a4-inh | 0.751 |
| CYP3a4-sub | 0.955 |
| CL | 9.065 |
| T12 | 0.104 |
| hERG | 0.969 |
| Ames | 0.187 |
| ROA | 0.576 |
| SkinSen | 0.845 |
| Carcinogencity | 0.139 |
| EI | 0.007 |
| Respiratory | 0.799 |
| NR-Aromatase | 0.34 |
| Antiviral | Yes |
| Prediction | 0.742587 |